Clinical trials
Phase 2/3 Anemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Active, not recruiting | 3 |
| Unknown status | 3 |
| Recruiting | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ain Shams University | 1 |
| Bristol-Myers Squibb | 1 |
| Centre For International Health | 1 |
| Claudia Sue Robertson | 1 |
| Cure HHT | 1 |
| ESI-PGIMSR, Basaidarapur | 1 |
| Hospital Universitario Dr. Jose E. Gonzalez | 1 |
| Hospital de Clinicas de Porto Alegre | 1 |
| Huazhong University of Science and Technology | 1 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia | 22 |
| Anemia, Iron-Deficiency | 2 |
| Iron Deficiencies | 2 |
| Myelodysplastic Syndromes | 2 |
| Anemia, Hemolytic, Autoimmune | 1 |
| Brain Injuries, Traumatic | 1 |
| Breast Diseases | 1 |
| Constipation | 1 |
| Critical Illness | 1 |
| Epistaxis | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.